The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era. Garcia-Illescas D, Mazzeo R, Garcia-Duran C, Oaknin A, et al. Curr Opin Obstet Gynecol 2024 Jan 3. doi: 10.1097/GCO.0000000000000934.

Read + Share

Amedeo Smart

Independent Medical Education

Garcia-Illescas D, Mazzeo R, Garcia-Duran C, Oaknin A, et al. The evolving landscape of antibody-drug conjugates in ovarian cancer: new drugs for a new era. Curr Opin Obstet Gynecol 2024 Jan 3. doi: 10.1097/GCO.0000000000000934.
PMID: 38170620